Administering

Risk assessment of preparation of monoclonal antibodies

27 June 2025A systematic approach to occupational risk assessment informs decisions about safe working practices with monoclonal antibodies (mAb)

Safe handling of monoclonal antibodies

27 June 2025Considerations for occupational safety when preparing monoclonal antibodies (mAb)

Choosing between oral vancomycin options

18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.

Choosing between fidaxomicin options

18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.

Supply and administration of medicines by staff group (H to O)

17 June 2025Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.

Patient Group Direction use in End of Life Care

2 June 2025Considerations required before implementing Patient Group Directions (PGDs) in End of Life Care.

Supply and/or administration of Controlled Drugs under a PGD

2 June 2025The legal position on the supply and/or administration of controlled drugs under Patient Group Directions is summarised

Off label medicine use under a Patient Group Direction

2 June 2025This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').

Unlicensed medicines and use of PGDs

2 June 2025This page explains why PGDs are not a legal mechanism for the administration or supply of unlicensed medicines.

Considerations for using medicines following bariatric surgery

30 May 2025Guidance on the physiological changes after bariatric surgery that can affect the pharmacokinetics of medicines and supplements.